These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23975096)

  • 21. The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.
    Fisher JL
    Neuropharmacology; 2015 Dec; 99():471-80. PubMed ID: 26277340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure, Function, and Regulation of the Kainate Receptor.
    Dhingra S; Yadav J; Kumar J
    Subcell Biochem; 2022; 99():317-350. PubMed ID: 36151381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons from crystal structures of kainate receptors.
    Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
    Neuropharmacology; 2017 Jan; 112(Pt A):16-28. PubMed ID: 27236079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacological profile of the high-affinity GluK5 kainate receptor.
    Møllerud S; Kastrup JS; Pickering DS
    Eur J Pharmacol; 2016 Oct; 788():315-320. PubMed ID: 27373850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and compositional diversity in the kainate receptor family.
    Selvakumar P; Lee J; Khanra N; He C; Munguba H; Kiese L; Broichhagen J; Reiner A; Levitz J; Meyerson JR
    Cell Rep; 2021 Oct; 37(4):109891. PubMed ID: 34706237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of kainate receptors in inner and outer hair cell synapses.
    Fujikawa T; Petralia RS; Fitzgerald TS; Wang YX; Millis B; Morgado-Díaz JA; Kitamura K; Kachar B
    Hear Res; 2014 Aug; 314():20-32. PubMed ID: 24858010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype.
    Chałupnik P; Vialko A; Pickering DS; Hinkkanen M; Donbosco S; Møller TC; Jensen AA; Nielsen B; Bay Y; Kristensen AS; Johansen TN; Łątka K; Bajda M; Szymańska E
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of group I metabotropic glutamate receptors potentiates heteromeric kainate receptors.
    Rojas A; Wetherington J; Shaw R; Serrano G; Swanger S; Dingledine R
    Mol Pharmacol; 2013 Jan; 83(1):106-21. PubMed ID: 23066089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist.
    More JC; Nistico R; Dolman NP; Clarke VR; Alt AJ; Ogden AM; Buelens FP; Troop HM; Kelland EE; Pilato F; Bleakman D; Bortolotto ZA; Collingridge GL; Jane DE
    Neuropharmacology; 2004 Jul; 47(1):46-64. PubMed ID: 15165833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neto proteins regulate gating of the kainate-type glutamate receptor GluK2 through two binding sites.
    Li YJ; Duan GF; Sun JH; Wu D; Ye C; Zang YY; Chen GQ; Shi YY; Wang J; Zhang W; Shi YS
    J Biol Chem; 2019 Nov; 294(47):17889-17902. PubMed ID: 31628192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structures of the glutamate receptor ion channel GluK3 and GluK5 amino-terminal domains.
    Kumar J; Mayer ML
    J Mol Biol; 2010 Dec; 404(4):680-96. PubMed ID: 20951142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neto2 modulation of kainate receptors with different subunit compositions.
    Straub C; Zhang W; Howe JR
    J Neurosci; 2011 Jun; 31(22):8078-82. PubMed ID: 21632929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlating efficacy and desensitization with GluK2 ligand-binding domain movements.
    Nayeem N; Mayans O; Green T
    Open Biol; 2013 May; 3(5):130051. PubMed ID: 23720540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Antiseizure Drug Perampanel Is a Subunit-Selective Negative Allosteric Modulator of Kainate Receptors.
    Taniguchi S; Stolz JR; Swanson GT
    J Neurosci; 2022 Jul; 42(28):5499-5509. PubMed ID: 35654603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine.
    Frydenvang K; Lash LL; Naur P; Postila PA; Pickering DS; Smith CM; Gajhede M; Sasaki M; Sakai R; Pentikaïnen OT; Swanson GT; Kastrup JS
    J Biol Chem; 2009 May; 284(21):14219-29. PubMed ID: 19297335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.
    Unno M; Shinohara M; Takayama K; Tanaka H; Teruya K; Doh-ura K; Sakai R; Sasaki M; Ikeda-Saito M
    J Mol Biol; 2011 Oct; 413(3):667-83. PubMed ID: 21893069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A kainate receptor-selective RNA aptamer.
    Jaremko W; Huang Z; Karl N; Pierce VD; Lynch J; Niu L
    J Biol Chem; 2020 May; 295(19):6280-6288. PubMed ID: 32161119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism of recombinant and native GluK3-containing kainate receptors.
    Perrais D; Pinheiro PS; Jane DE; Mulle C
    Neuropharmacology; 2009 Jan; 56(1):131-40. PubMed ID: 18761361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of critical functional determinants of kainate receptor modulation by auxiliary protein Neto2.
    Griffith TN; Swanson GT
    J Physiol; 2015 Nov; 593(22):4815-33. PubMed ID: 26282342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.
    Lash-Van Wyhe LL; Postila PA; Tsubone K; Sasaki M; Pentikäinen OT; Sakai R; Swanson GT
    Neuropharmacology; 2010 Mar; 58(3):640-9. PubMed ID: 19962997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.